Insights into Streptococcus pyogenes pathogenesis from transcriptome studies

Future Microbiology

Volumn 5, Issue 11, 2010, Pages 1675-1694

  Fiedler, Tomas ^a   Sugareva, Venelina ^a   Patenge, Nadja ^a   Kreikemeyer, Bernd ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

pathogenesis; regulation; Streptococcus pyogenes; transcriptome; virulence factor

Indexed keywords

PROTEIN; PROTEIN COVRS; PROTEIN MGA; PROTEIN MSMR; PROTEIN RALP; PROTEIN RALP 2; PROTEIN RGG; PROTEIN ROPB; PROTEIN SPEB; PROTEIN SPTRS; PROTEIN SRV; SODIUM CHLORIDE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ACIDITY; BACTERIAL GROWTH; BACTERIUM PILUS; BLOOD; EPIDEMIOLOGICAL DATA; GENE CONTROL; GENE EXPRESSION; HOST CELL; IMMUNOCOMPETENT CELL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHARYNGITIS; PHARYNX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SALIVA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TEMPERATURE; VIRULENCE; WILD TYPE;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); EUKARYOTA; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 78650199638     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.128     Document Type: Review

References (102)

1. Lancefeld RC: A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57(4), 571-595 (1933).
2. Cunningham MW: Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13(3), 470-511 (2000).
3. Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5(11), 685-694 (2005).
4. Courtney HS, Hasty DL, Dale JB: Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann. Med. 34(2), 77-87 (2002).
5. Kreikemeyer B, Klenk M, Podbielski A: The intracellular status of Streptococcus pyogenes: role of extracellular matrix-binding proteins and their regulation. Int. J. Med. Microbiol 294(2-3), 177-188 (2004).
6. Patti JM, Allen BL, McGavin MJ, Hook M: MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48, 585-617 (1994).
7. Kreikemeyer B, McIver KS, Podbielski A: Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 11(5), 224-232 (2003).
8. Osterlund A, Engstrand L: An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium - studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol. 117(6), 883-888 (1997).
9. Podbielski A, Kreikemeyer B: Persistence of group A streptococci in eukaryotic cells - a safe place? Lancet 358(9275) , 3-4 (2001).
10. Podbielski A, Beckert S, Schattke R et al.: Epidemiology and virulence gene expression of intracellular group A streptococci in tonsils of recurrently infected adults. Int. J. Med. Microbiol. 293(2-3), 179-190 (2003).
11. Lancefeld RC: The antigenic complex of Streptococcus haemolyticus: I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus. J. Exp. Med. 47(1), 91-103 (1928).
12. Lancefeld RC: Current knowledge of type-specific M antigens of group A streptococci. J Immunol 89(3), 307-313 (1962).
13. Facklam RR: Screening for streptococcal pharyngitis: current technology. Infect. Med. 14, 891-898 (1997).
14. Beall B, Facklam R, Thompson T: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34(4), 953-958 (1996).
15. Podbielski A, Melzer B, Lutticken R: Application of the polymerase chain reaction to study the M protein(-like) gene family in b-hemolytic streptococci. Med. Microbiol. Immunol. 180(4), 213-227 (1991).
16. Kaufhold A, Podbielski A, Baumgarten G et al.: Rapid typing of group A streptococci by the use of DNA amplifcation and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiol. Lett. 119(1-2), 19-25 (1994). (Pubitemid 124012158)
17. Moody MD, Padula J, Lizana D, Hall CT: Epidemiologic characterization of group A streptococci by T-agglutination and M-precipitation tests in the public health laboratory. Health Lab. Sci. 2, 149-162 (1965).
18. Top FH Jr, Wannamaker LW: The serum opacity reaction of Streptococcus pyogenes: the demonstration of multiple, strain-specific lipoproteinase antigenes. J. Exp. Med. 127(5), 1013-1034 (1968).
19. Bessen DE, Carapetis JR, Beall B et al.: Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J. Infect. Dis. 182(4), 1109-1116 (2000).
20. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE: Multilocus sequence typing of Streptococcus pyogenes and the relationships between EMM type and clone. Infect. Immun. 69(4), 2416-2427 (2001).
21. Martin JM, Wald ER, Green M: Field inversion gel electrophoresis as a typing system for group A Streptococcus. J. Infect. Dis. 177(2), 504-507 (1998).
22. Falugi F, Zingaretti C, Pinto V et al.: Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefeld T serotypes. J. Infect. Dis. 198(12), 1834-1841 (2008).
23. Koeller T, Manetti AGO, Kreikemeyer B et al.: Pilus protein encoding FCT region typing and bioflm formation as novel parameters in epidemiological investigations on S. pyogenes isolates from various infection sites. J. Med. Microbiol. 59, 442-452 (2010).
24. Banks DJ, Porcella SF, Barbian KD et al.: Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. J. Infect. Dis. 190(4), 727-738 (2004).
25. Beres SB, Sylva GL, Barbian KD et al.: Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl Acad. Sci. USA 99(15), 10078-10083 (2002).
26. Green NM, Zhang S, Porcella SF et al.: Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192(5), 760-770 (2005).
27. Ferretti JJ, McShan WM, Ajdic D et al.: Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl Acad. Sci. USA 98(8), 4658-4663 (2001).
28. Holden MT, Scott A, Cherevach I et al.: Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain manfredo. J. Bacteriol. 189(4), 1473-1477 (2007).
29. McShan WM, Ferretti JJ, Karasawa T et al.: Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J. Bacteriol. 190(23), 7773-7785 (2008).
30. Nakagawa I, Kurokawa K, Yamashita A et al.: Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. Genome Res. 13 (6A), 1042-1055 (2003).
31. Smoot JC, Barbian KD, Van Gompel JJ et al.: Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl Acad. Sci. USA 99(7), 4668-4673 (2002).
32. Sumby P, Porcella SF, Madrigal AG et al.: Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192(5), 771-782 (2005).
33. Tart AH, Walker MJ, Musser JM: New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol. 15(7), 318-325 (2007).
34. Banks DJ, Beres SB, Musser JM: The fundamental contribution of phages to GAS evolution, genome diversifcation and strain emergence. Trends Microbiol. 10(11), 515-521 (2002).
35. Hondorp ER, McIver KS: The Mga virulence regulon: infection where the grass is greener. Mol. Microbiol. 66(5), 1056-1065 (2007).
36. McIver KS: Stand-alone response regulators controlling global virulence networks in Streptococcus pyogenes. Contrib. Microbiol. 16, 103-119 (2009).
37. Olsen RJ, Shelburne SA, Musser JM: Molecular mechanisms underlying group A streptococcal pathogenesis. Cell. Microbiol. 11(1), 1-12 (2009).
38. Bessen DE, Lizano S: Tissue tropisms in group A streptococcal infections. Future Microbiol. 5(4), 623-638 (2010).
39. Beyer-Sehlmeyer G, Kreikemeyer B, Horster A, Podbielski A: Analysis of the growth phase-associated transcriptome of Streptococcus pyogenes. Int. J. Med. Microbiol. 295(3), 161-177 (2005).
40. Chaussee MA, Dmitriev AV, Callegari EA, Chaussee MS: Growth phase-associated changes in the transcriptome and proteome of Streptococcus pyogenes. Arch. Microbiol. 189(1), 27-41 (2008).
41. Barnett TC, Bugrysheva JV, Scott JR: Role of mRNA stability in growth phase regulation of gene expression in the group A Streptococcus. J. Bacteriol. 189(5), 1866-1873 (2007).
42. Smoot LM, Smoot JC, Graham MR et al.: Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc. Natl Acad. Sci. USA 98(18), 10416-10421 (2001).
43. Loughman JA, Caparon M: Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J. Bacteriol. 188(2), 399-408 (2006).
44. Graham MR, Virtaneva K, Porcella SF et al.: Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am. J. Pathol. 166(2), 455-465 (2005).
45. Shelburne SA 3rd, Sumby P, Sitkiewicz I et al.: Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc. Natl Acad. Sci. USA 102(44), 16037-16042 (2005).
46. Malke H, Ferretti JJ: CodY-affected transcriptional gene expression of Streptococcus pyogenes during growth in human blood. J. Med. Microbiol. 56(Pt 6), 707-714 (2007).
47. Volkov A, Liavonchanka A, Kamneva O et al.: Myosin cross-reactive antigen of Streptococcus pyogenes M49 encodes a fatty acid double bond hydratase that plays a role in oleic acid detoxifcation and bacterial virulence. J. Biol. Chem. 285, 10353-10361 (2010).
48. Voyich JM, Sturdevant DE, Braughton KR et al.: Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc. Natl Acad. Sci. USA 100(4), 1996-2001 (2003).
49. Virtaneva K, Porcella SF, Graham MR et al.: Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc. Natl Acad. Sci. USA 102(25), 9014-9019 (2005).
50. Graham MR, Virtaneva K, Porcella SF et al.: Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am. J. Pathol. 169(3), 927-942 (2006).
51. Shea PR, Virtaneva K, Kupko JJ 3rd et al.: Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc. Natl Acad. Sci. USA 107(10), 4693-4698 (2010).
52. Olsen RJ, Sitkiewicz I, Ayeras AA et al.: Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc. Natl Acad. Sci. USA 107(2), 888-893 (2010).
53. Nakagawa I, Nakata M, Kawabata S, Hamada S: Transcriptome analysis and gene expression profles of early apoptosis-related genes in Streptococcus pyogenes-infected epithelial cells. Cell. Microbiol. 6(10), 939-952 (2004).
54. Klenk M, Koczan D, Guthke R et al.: Global epithelial cell transcriptional responses reveal Streptococcus pyogenes Fas regulator activity association with bacterial aggressiveness. Cell. Microbiol. 7(9), 1237-1250 (2005).
55. Klenk M, Nakata M, Podbielski A et al.: Streptococcus pyogenes serotype-dependent and independent changes in infected HEp-2 epithelial cells. ISME J. 1(8), 678-692 (2007).
56. Goldmann O, von Kockritz-Blickwede M, Holtje C et al.: Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect. Immun. 75(8), 4148-4157 (2007).
57. Sumby P, Barbian KD, Gardner DJ et al.: Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl Acad. Sci. USA 102(5), 1679-1684 (2005).
58. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM: Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2(1), E5 (2006).
59. Aziz RK, Kansal R, Aronow BJ et al.: Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation, and hypervirulence. PLoS One 5(4), E9798 (2010).
60. Miyoshi-Akiyama T, Ikebe T, Watanabe H et al.: Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A Streptococcus clinical isolate. J. Infect. Dis. 193(12), 1677-1684 (2006).
61. Beres SB, Carroll RK, Shea PR et al.: Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc. Natl Acad. Sci. USA 107(9), 4371-4376 (2010).
62. Caparon MG, Scott JR: Identifcation of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc. Natl Acad. Sci. USA 84(23), 8677-8681 (1987).
63. Ribardo DA, McIver KS: Defining the Mga regulon: comparative transcriptome analysis reveals both direct and indirect regulation by Mga in the group A Streptococcus. Mol. Microbiol. 62(2), 491-508 (2006).
64. Podbielski A, Woischnik M, Leonard BA, Schmidt KH: Characterization of nra, a global negative regulator gene in group A streptococci. Mol. Microbiol. 31(4), 1051-1064 (1999).
65. Kratovac Z, Manoharan A, Luo F, Lizano S, Bessen DE: Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J. Bacteriol. 189(4), 1299-1310 (2007).
66. Kreikemeyer B, Beckert S, Braun-Kiewnick A, Podbielski A: Group A streptococcal RofA-type global regulators exhibit a strain-specific genomic presence and regulation pattern. Microbiology 148(5), 1501-1511 (2002). (Pubitemid 34567228)
67. Beckert S, Kreikemeyer B, Podbielski A: Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect. Immun. 69(1), 534-537 (2001).
68. Kreikemeyer B, Nakata M, Koller T et al.: The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region. Infect. Immun. 75(12), 5698-5710 (2007).
69. Nakata M, Podbielski A, Kreikemeyer B: MsmR, a specific positive regulator of the Streptococcus pyogenes FCT pathogenicity region and cytolysin-mediated translocation system genes. Mol. Microbiol. 57(3), 786-803 (2005).
70. Levin JC, Wessels MR: Identifcation of csrR/ csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol. Microbiol. 30(1), 209-219 (1998).
71. Graham MR, Smoot LM, Migliaccio CA et al.: Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profling and in vivo infection modeling. Proc. Natl Acad. Sci. USA 99(21), 13855-13860 (2002).
72. Dalton TL, Collins JT, Barnett TC, Scott JR: RscA, a member of the MDR1 family of transporters, is repressed by CovR and required for growth of Streptococcus pyogenes under heat stress. J. Bacteriol. 188(1), 77-85 (2006).
73. Roberts SA, Churchward GG, Scott JR: Unraveling the regulatory network in Streptococcus pyogenes: the global response regulator CovR represses rivR directly J. Bacteriol. 189(4), 1459-1463 (2007).
74. Roberts SA, Scott JR: RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol. Microbiol. 66(6), 1506-1522 (2007).
75. Leday TV, Gold KM, Kinkel TL et al.: TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus. Infect. Immun. 76(10), 4659-4668 (2008).
76. Churchward G: The two faces of Janus: virulence gene regulation by CovR/S in group A streptococci. Mol. Microbiol. 64(1), 34-41 (2007).
77. Froehlich BJ, Bates C, Scott JR: Streptococcus pyogenes CovRS mediates growth in iron starvation and in the presence of the human cationic antimicrobial peptide LL-37 J. Bacteriol. 191(2), 673-677 (2009).
78. Dalton TL, Scott JR: CovS inactivates CovR and is required for growth under conditions of general stress in Streptococcus pyogenes. J. Bacteriol. 186(12), 3928-3937 (2004).
79. Gryllos I, Grifantini R, Colaprico A et al.: Mg(2+) signalling defnes the group A streptococcal CsrRS (CovRS) regulon. Mol. Microbiol. 65(3), 671-683 (2007).
80. Musser JM, Deleo FR: Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am. J. Pathol. 167(6), 1461-1472 (2005).
81. Heath A, DiRita VJ, Barg NL, Engleberg NC: A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect. Immun. 67(10), 5298-5305 (1999).
82. Trevino J, Perez N, Ramirez-Pena E et al.: CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect. Immun. 77(8), 3141-3149 (2009).
83. Biswas I, Scott JR: Identifcation of rocA, a positive regulator of covR expression in the group A Streptococcus. J. Bacteriol. 185(10), 3081-3090 (2003).
84. Reid SD, Chaussee MS, Doern CD et al.: Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB. FEMS Immunol. Med. Microbiol. 48(2), 283-292 (2006).
85. Chaussee MS, Sylva GL, Sturdevant DE et al.: Rgg infuences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect. Immun. 70(2), 762-770 (2002).
86. Chaussee MS, Somerville GA, Reitzer L, Musser JM: Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J. Bacteriol. 185(20), 6016-6024 (2003).
87. Dmitriev AV, McDowell EJ, Kappeler KV et al.: The Rgg regulator of Streptococcus pyogenes infuences utilization of nonglucose carbohydrates, prophage induction, and expression of the NAD-glycohydrolase virulence operon. J. Bacteriol. 188(20), 7230-7241 (2006).
88. Dmitriev AV, McDowell EJ, Chaussee MS: Inter- and intraserotypic variation in the Streptococcus pyogenes Rgg regulon. FEMS Microbiol. Lett. 284(1), 43-51 (2008).
89. Sitkiewicz I, Musser JM: Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a Streptococcus. Infect. Immun. 74(2), 1339-1351 (2006).
90. Kinkel TL, McIver KS: CcpA-mediated repression of streptolysin S expression and virulence in the group A Streptococcus. Infect. Immun. 76(8), 3451-3463 (2008).
91. Shelburne SA III, Keith D, Horstmann N et al.: A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc. Natl Acad. Sci. USA 105(5), 1698-1703 (2008).
92. Brenot A, Weston BF, Caparon MG: A PerR-regulated metal transporter (PmtA) is an interface between oxidative stress and metal homeostasis in Streptococcus pyogenes. Mol. Microbiol. 63(4), 1185-1196 (2007).
93. Gryllos I, Grifantini R, Colaprico A et al.: PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus. PLoS Pathog. 4(9), e1000145 (2008).
94. Toukoki C, Gold KM, McIver KS, Eichenbaum Z: MtsR is a dual regulator that controls virulence genes and metabolic functions in addition to metal homeostasis in the group A Streptococcus. Mol. Microbiol. 76(4), 971-989 (2010).
95. Riani C, Standar K, Srimuang S et al.: Transcriptome analyses extend understanding of Streptococcus pyogenes regulatory mechanisms and behavior toward immunomodulatory substances. Int. J. Med. Microbiol. 297(7-8), 513-523 (2007).
96. Liu M, Hanks TS, Zhang J et al.: Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR. Microbiology 152(Pt 4), 967-978 (2006).
97. Voyich JM, Braughton KR, Sturdevant DE et al.: Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J. Immunol. 173(2), 1194-1201 (2004).
98. Lefebure T, Stanhope MJ: Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition. Genome Biol. 8(5), R71 (2007).
99. Steer AC, Batzloff MR, Mulholland K, Carapetis JR: Group A streptococcal vaccines: facts versus fantasy. Curr. Opin. Infect. Dis. 22(6), 544-552 (2009).
100. Sharma CM, Hoffmann S, Darfeuille F et al.: The primary transcriptome of the major human pathogen Helicobacter pylori. Nature 464(7286), 250-255 (2010).
101. Kreikemeyer B, Boyle MD, Buttaro BA, Heinemann M, Podbielski A: Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol. Microbiol. 39(2), 392-406 (2001).
102. Perez N, Trevino J, Liu Z et al.: A genome- wide analysis of small regulatory RNAs in the human pathogen group A Streptococcus. PLoS One 4(11), e7668 (2009).